June 17 (Reuters) – ImmuneOnco Biopharmaceuticals (Shanghai) Inc: * TO SUBSCRIBE FOR WEALTH MANAGEMENT PRODUCT FOR HK$87.5 MILLION FROM VITAL VENTURES Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)